Clinical Study for the Efficacy and Safety of Ropeginterferon Alfa-2b in Moderate COVID19.
Clinical trial NCT05770466 · COMPLETED
Trial details
- NCT number
- NCT05770466
- Sponsor
- National Taiwan University Hospital
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-01
- Primary completion
- 2022-12-21
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.